Merck & Co Inc ((MRK)) Lobbying Data
(MRK) lobbying summary
Merck & Co Inc ((MRK)) has reported $70.4M in federal lobbying spending across 58 Senate LDA filings since 2020. Its most frequent lobbying issues are Taxation, Medicare/Medicaid, Health Issues, Animals. Lobbying firms used include Williams and Jensen, Pllc, Merck & Co, Inc..
Lobbying spending by year
| Year | Reported spend |
|---|---|
| 2026 | $9.0M |
| 2025 | $16.2M |
| 2024 | $11.1M |
| 2023 | $10.2M |
| 2022 | $8.4M |
| 2021 | $8.2M |
See insider trading for (MRK) or the Lobbying Heavyweights strategy.
Source: Senate Lobbying Disclosure Act (LD-2) filings. The current year is partial.